









Markets
/
Stocks
/
nasdaq-eprx
/

Eupraxia Pharmaceuticals Inc

EPRX

View Detailed Chart

5.310USD

+0.050+0.95%

Market hours （ET）Quotes delayed by 15 min

190.36MMarket Cap

LossP/E TTM



Eupraxia Pharmaceuticals Inc

5.310

+0.050+0.95%

Overview Company Financials

Financials

Intraday

30m

Today

+0.95%

5 Days

-3.28%

1 Month

-1.48%

6 Months

+75.06%

Year to Date

+67.51%

1 Year

+106.61%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts

BUY

Current Rating

11.750

Target Price

123.38%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Eupraxia Pharmaceuticals Inc

EPRX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(4)

Buy(3)

Indicators

Sell(2)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.110

Neutral

RSI(14)

51.568

Neutral

STOCH(KDJ)(9,3,3)

56.286

Sell

ATR(14)

0.261

High Vlolatility

CCI(14)

-49.451

Neutral

Williams %R

53.086

Neutral

TRIX(12,20)

0.480

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

5.441

Sell

MA10

5.361

Sell

MA20

5.403

Sell

MA50

4.738

Buy

MA100

4.198

Buy

MA200

3.669

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release products. The Company’s lead product candidate, EP-104, is designed to address the significant unmet medical need and market demand for conditions where long-lasting symptom relief is essential to effective treatment. The primary targets for EP-104 have been identified as knee osteoarthritis (OA) and eosinophilic esophagitis (EoE). The product in development for OA is called EP-104IAR and the product in development in EoE is called EP-104GI. DiffuSphere, a proprietary, polymer based micro-sphere technology, is designed to facilitate targeted drug delivery, with extended duration of effect, and offers multiple, highly tunable pharmacokinetic (PK) profiles.

Ticker SymbolEPRX

CompanyEupraxia Pharmaceuticals Inc

CEODr. James A. Helliwell, M.D.

Websitehttps://eupraxiapharma.com/home/default.aspx